NLRP3 and neoplasm: When inhibiting the expression of LncRNA-XIST oncogene, it could activate NLRP3 inflammatory bodies, increase the expression of caspase-1 and IL-1β, and then induce pyroptosis of tumor cells, ultimately inhibiting the occurrence and development of NSCLC.